Chidamide; Decitabine; Anti-PD-1 Antibody

DRUG2 trials

Sponsors

Chinese PLA General Hospital

Conditions

Ineligible Or Refused Transplant Patients With Classical Hodgkin Lymphoma

Phase 2

Chidamide Decitabine Plus Anti-PD-1 Antibody for Patients With R/R cHL Who Are Transplant-ineligible or Refused Transplant.

RecruitingNCT06393361

Chinese PLA General HospitalIneligible Or Refused Transplant Patients With Classical Hodgkin Lymphoma

Start: 2024-06-01End: 2027-06-01Target: 100Updated: 2026-01-02

Chidamide+Decitabine Plus Anti-PD-1 Antibody for Patients With R/R cHL Who Are Transplant-ineligible or Refused Transplant.

Not yet recruitingNCT06563778

Chinese PLA General HospitalIneligible Or Refused Transplant Patients With Classical Hodgkin Lymphoma

Start: 2024-09-01End: 2028-09-01Target: 100Updated: 2024-08-21